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Abstract
Six transmembrane protein of prostate (Stamp) proteins play an important role in prostate cancer cell growth. Recently, we
found that Stamp2 has a critical role in the integration of inflammatory and metabolic signals in adipose tissue where it is
highly expressed and regulated by nutritional and metabolic cues. In this study, we show that all Stamp family members are
differentially regulated during adipogenesis: whereas Stamp1 expression is significantly decreased upon differentiation,
Stamp2 expression is increased. In contrast, Stamp3 expression is modestly changed in adipocytes compared to
preadipocytes, and has a biphasic expression pattern during the course of differentiation. Suppression of Stamp1 or Stamp2
expression both led to inhibition of 3T3-L1 differentiation in concert with diminished expression of the key regulators of
adipogenesis - CCAAT/enhancer binding protein alpha (C/ebpa) and peroxisome proliferator-activated receptor gamma
(Pparc). Upon Stamp1 knockdown, mitotic clonal expansion was also inhibited. In contrast, Stamp2 knockdown did not
affect mitotic clonal expansion, but resulted in a marked decrease in superoxide production that is known to affect
adipogenesis. These results suggest that Stamp1 and Stamp2 play critical roles in adipogenesis, but through different
mechanisms.
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Introduction
Over the last decades, there has been a dramatic increase in the
prevalence of obesity. A recent estimate indicated that more than
1.5 billion people world-wide are overweight or obese [1]. This is a
consequence of imbalances in expenditure and intake of energy
along with changes in nutrition sources [2]. Obesity is linked to an
increased risk of developing various diseases such as type 2
diabetes, cardiovascular disease, hepatic steatosis, airway disease,
neurodegeneration, biliary disease, and certain cancers [3]. These
maladies are now among the leading causes of death worldwide
[4].
The increase in obesity has focused attention on adipose tissue
function and development. Adipogenesis, the process by which
fibroblastic precursor cells or preadipocytes are converted into
mature adipocytes, has been one of the most intensively studied
model systems for cellular differentiation [5]. Most of the
adipogenesis research has utilized pre-adipocyte cell culture
models (e.g. the murine cell lines 3T3-L1 and 3T3-F442A) [6].
For 3T3-L1 cells, a hormonal mixture commonly containing
dexamethasone, isobutylmethylxanthine and insulin is used to
activate signaling pathways which initiate a cascade of transcrip-
tion factors that drive the adipogenic program through the stages
of mitotic clonal expansion, growth arrest, and terminal differen-
tiation [7,8]. The nuclear receptor Pparc and members of the C/
ebp family are critical determinants of this process together with
an assembly of transcriptional co-regulators. More recently, new
mechanisms and cellular processes regulating the adipogenic
conversion have been reported (for a brief overview, see [9]). Of
these, oxidative stress and reactive oxygen species (ROS) have
been implicated in pre-adipocyte differentiation [10]. ROS can
affect the preadipocytes as both an external or internal signal, and
depending on the source and localization, it may either promote or
inhibit differentiation in a given model system [11–16].
The Stamp family of proteins (also known as STEAPs) consists
of three members (Stamp1-3) that share high sequence similarity
in the putative six-transmembrane domain; a region homologous
to F(420)H(2):NADP(+) oxidoreductases found in archaea and
bacteria, as well as to the yeast FRE family of metalloreductases
[17]. All Stamps have metalloreductase activity in HEK293T cells
[18]. Furthermore, Stamp3 has been shown to be essential for
normal iron metabolism in mice [19]. Stamp2 expression is
induced by tumor necrosis factor alpha (TNFa) in 3T3-L1 cells
(thus also called TNFa-induced adipose-related protein (Tiarp))
and its expression is increased during differentiation [20]. In
addition, studies in knockout mice showed that Stamp2 integrates
inflammatory and nutritional signaling in mice on a regular diet
[21]. More recently, we have found that Stamp2 controls
intermediary metabolites to regulate inflammatory responses and
atherosclerosis in mice [22]. Human STAMP2 expression in
human adipocytes is stimulated by TNFa and interleukin 6, and
STAMP2 levels positively correlate with insulin sensitivity [23,24].
Furthermore, recent human studies found STAMP2 expression
decreased in obese and/or insulin resistant individuals [25–27].
These findings point to a protective role of Stamp2 in adipose
tissue function in both human and mice. However, a recent report
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found that STAMP2 expression was increased in obese patients
and this was linked to reduced insulin response in isolated
adipocytes [28].
Here, we investigated the expression of the Stamp family during
adipogenic conversion of 3T3-L1 cells, and show that they are
differentially regulated during adipogenesis with distinct profiles.
We also show that both Stamp1 and Stamp2 affect 3T3-L1
adipogenesis. Herein we explore the molecular details of this
process.
Materials and Methods
Cell Lines and Cell Culture
3T3-L1 cell line (a generous gift from the lab of Go¨khan S.
Hotamisligil, ATCC, CL-173) was maintained in Dulbecco’s
modified Eagle’s medium (DMEM) (Lonza) supplemented with
10% fetal bovine serum (FBS) (Saveen Werner), 50 U/ml
penicillin-streptomycin (Lonza) and 2 mM L-Glutamine (Lonza)
in a 5% CO2 humidified atmosphere. 3T3-L1 cells were
differentiated to adipocytes by adding standard adipogenic cocktail
(0.5 mM methylisobutylxanthine [Sigma-Aldrich], 5 mg/ml insu-
lin [Sigma-Aldrich], and 1 mM dexamethasone [Sigma-Aldrich])
to post-confluent cells. 48 h later, cells were re-fed with normal
growth medium containing 5 mg/ml insulin every second day until
day 8. When indicated, 1 mM pioglitazone (Pio) (Sigma-Aldrich)
was added to the adipogenic cocktail.
Lentivirus Production and Establishment of Stable 3T3-L1
Cell Lines
pLKO.1 plasmids (Sigma-Aldrich) containing shRNA against
Stamp1 (sh-St1_1 [TRCN0000253445] and sh-St1_2
[TRCN0000253448]), Stamp2 (sh-St2_1 [TRCN0000249066]
and sh-St2_2 [TRCN0000249065]) or green fluorescent protein
(GFP) (shGFP) were transfected together with a packaging plasmid
(pCMV-DR8.2) and an envelope plasmid (pCMV-VGS-G) into
HEK293T cells using Fugene 6 (Invitrogen). 48 h post transfection
conditioned medium was harvested, filtered through a 0.45 mm
filter (Millipore) and added to 3T3-L1 fibroblasts. 36 h post
infection the 3T3-L1 cells were subjected to selection with 2 mg/
ml puromycin for 7 days after which the cells were maintained in
medium with 1 mg/ml puromycin. Unless specified, sh-St1_1 and
sh-St2_1 cells were used in the experiments presented.
Immunofluoresence Microscopy
3T3-L1 cells were plated on cover slips, grown to post
confluency and treated with adipogenic cocktail for 16 h. Cells
were washed briefly with phosphate buffered saline (PBS) and
fixed in methanol at 220uC for 5 min. Cells were then blocked
with 1% BSA (Sigma-Aldrich) for 30 min before incubation with
C/ebpb antiserum (1:100) (Abcam, ab32358) at 4uC overnight
and incubated with Alexa Fluor 488 goat anti-rabbit secondary
antibodies (1:500) (Invitrogen) for 1 h at room temperature. DAPI
(Sigma-Aldrich) staining was used for visualizing the nuclei.
Images were acquired with an Olympus FlowView FV1000.
Oil Red O Staining
The cells were washed briefly with PBS and then fixed with
0.5% gluteraldehyde in PBS followed by washes with PBS and
60% isopropanol (Arcus) in PBS. The cells were then stained in
Oil Red O solution (3 parts Oil Red O [0.5 g [Sigma-Aldrich] in
200 ml isopropanol] and 2 parts MQ water) for 15 min and
washed with 60% isopropanol followed by a final wash in PBS.
Images were taken with an AxioCam HRc (Zeiss). For quantifi-
cation, the Oil Red O was extracted from the cells with 100%
isopropanol for 5 min. The extracts were clarified by centrifuga-
tion at 10,000 g for 2 min and absorbance at 460 nm was
determined with a multiplate reader (Victor2, PerkinElmer).
Cell Counting
At indicated stages of differentiation, the cells were washed with
PBS, dissociated with Trypsin EDTA (Lonza), diluted in DMEM
and counted using a haemocytometer.
NBT Assay
The cells were washed briefly with PBS and then incubated with
0.1 mg/ml Nitro Blue Tetrazolium (NBT) (Sigma-Aldrich) in PBS
at 37uC for 90 min to allow blue formazan crystals to form. The
cells were then washed with PBS and images were acquired with
an AxioCam HRc (Zeiss). To quantify the formazan produced, the
cells were lysed with a 2 M KOH/DMSO (Sigma-Aldrich) (1/
1.17, v/v) solution for 15 min. The lysate was clarified by
centrifugation at 10,000 g for 2 min and absorbance at 570 nm
was determined with a multiplate reader (Victor2, PerkinElmer).
Western Analysis
The cells were washed with PBS at the indicated time points
and protein extracts were made in lysis buffer (20 mM HEPES
[pH7.7], 0.3 M, NaCl 0.2 mM EDTA, 1.5 mM MgCl2, 1%
Triton X-100, 0.1% SDS with 1X Protease inhibitor cocktail
[Roche] and Phosphatase inhibitor cocktail [Roche]) for 1 h. 50–
100 mg of protein extract was resolved on a 10% polyacrylamide-
SDS gel, blotted to a PVDF membrane and incubated with
antisera against C/ebpb (1:500) (Abcam, ab32358), C/ebpa
(1:500) (Santa Cruz, sc-61), Pparc (1:1000) (a generous gift from
Professor H.I. Nebb, Santa Cruz, sc-7273), STEAP4 (1:500)
(Proteintech, 11944-1-AP) or b-actin (Sigma-Aldrich) (1:10000) in
5% BSA (1% for STEAP4 antibody) in Tris buffered saline (TBS)-
0.1% Tween. Images were obtained with a Kodak imaging station
4000R and the band intensities were determined using Carestream
Imaging Software.
Quantitative Reverse-transcription PCR (qRT-PCR)
Total RNA was extracted from cells using the Trizol reagent
(Invitrogen). mRNA transcripts were converted to cDNA by the
Superscript II (Invitrogen) reverse transcriptase using oligo(dT)
primers (Sigma-Aldrich). cDNA was quantified by the Lighty-
cler480 system using the SYBR Green dye (Roche). For each
primer pair the crossing point (CP) values of a given PCR for a
sample were set relative to the CP value of the wild type control
group, while also correcting for primer specific reaction efficiency
with an internal standard curve. The values were then normalized
to the expression of the ribosomal gene 36B4. All PCR products
were analyzed by melting curve analysis. qRT-PCR primer
sequences (all from Sigma-Aldrich) used in this study are as
follows: Stamp1, forward 59-ATA GGA AGT GGG GAT TTT
GC-39, reverse 59-AGA TGT CTC AGG TCC CAC AA-39;
Stamp2, forward 59- TCA CTT CCT TGC CAT CAG-39, reverse
59- GCT CCA CCT TAG AAT CGA AG-39; Stamp3, forward 59-
CCG TCC ATT GCT AAT TCC CTC-39, reverse 59- CGG
CAG GTA GAA CTT GTA GTG-39; aP2: forward 59-GTC
ACC ATC CGG TCA GAG AG-39, reverse 59-TCG ACT TTC
CAT CCC ACT TC-39; Pparc, forward 59-GCC CTT TGG TGA
CTT TAT GG-39, reverse 59-GGC GGT CTC CAC TGA GAA
TG-39; C/ebpa, forward 59-GCG GCA AAG CCA AGA AGT C-
39, reverse 59-GCG GTC ATT GTC ACT GGT CA-39; 36B4,
forward 59-AAG CGC GCG TCC TGG CAT TGT CT-39,
reverse 59-CCG CAG GGG CAG CAG TGG T-39.
Stamps in Adipogenesis
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Statistics
Statistical analyses were performed using the Student’s t-test.
Data are presented as means and error bars represent standard
deviation. Significance was defined as p,0.05. All analyses were
repeated with the Mann-Whitney-Wilcoxon (MWW) test, which
resulted in the same outcome as obtained with the Student’s t-test.
Results
Regulation of Stamp Expression during 3T3-L1
Adipogenesis
The increase in Stamp2 expression during 3T3-L1 differenti-
ation into adipocytes has been reported previously [20,21]. In
addition, Stamp3 protein level was slightly increased upon 3T3-L1
differentiation and decreased in the adipose tissue of rats fed a high
fat diet after a treatment with an anti-obesity drug [29,30]. To
investigate the coordinated expression of all Stamp family
members in the same system, we differentiated 3T3-L1 fibroblasts
into mature adipocytes and harvested proliferating cells (d-2),
postconfluent cells (d0), and cells differentiated for 2, 4, 6 and 8
days (d2-d8), isolated RNA, and determined Stamp mRNA
expression by qRT-PCR analysis (Figure 1). Stamp1 mRNA
expression was highest in proliferating 3T3-L1 fibroblasts
(Figure 1A). Upon confluency, there was an approximately 40%
reduction in Stamp1 expression which decreased a further 70% at
48 h. Interestingly, the Stamp1 expression rebounded at day 4 to
about twice that of day 2 and then declined again during the rest
of differentiation. Consistent with previous reports, Stamp2 mRNA
expression was low until day 4 when its expression increased to
about 4-fold higher than in proliferating cells (Figure 1B, top).
Stamp2 levels increased dramatically after that reaching 60-fold
higher levels by day 8 compared with what observed at day 0.
Consistently, Stamp2 protein levels were barely detectable at day 0
and increased by approximately 30-fold by day 8 of differentiation
(Figure 1B, bottom). In contrast to Stamp1 and Stamp2, Stamp3
expression showed a biphasic pattern rather than a distinct
directional regulation pattern as it increased approximately 2-fold
upon confluency, then dropped significantly to about 30% of this
level by day 2, and then continued to rise again reaching similar
levels of expression seen at confluency by day 8. Available antisera
for Stamp1 and Stamp3 did not function in Western analysis and
thus we were unable to explore relative changes to the protein
levels for these proteins (data not shown). These data show that all
Stamp family members are expressed in 3T3-L1 cells and are
differentially regulated during adipogenesis.
Knockdown of Stamp1 and Stamp2 Expression
Suppresses 3T3-L1 Adipogenesis
Since Stamp1 and Stamp2 expression were most significantly
affected during adipogenesis, we investigated the possible conse-
quence of their knockdown on 3T3-L1 differentiation. To that
end, we generated 3T3-L1 cell lines stably expressing short hairpin
RNAs (shRNAs) against either Stamp1 (sh-St1 cells) or Stamp2 (sh-
St2 cells), as well as Green Fluorescent Protein (GFP) (sh-GFP
cells). There was an approximately 90% and 95% knockdown,
respectively, of Stamp1 and Stamp2 expression, in these cell lines
compared to sh-GFP cells (Figures 2A and 2B). Moreover,
Western analysis showed that Stamp2 protein levels were reduced
by about 70% in sh-St2 adipocytes compared to that of sh-GFP
expressing or WT cells (Figure 2C).
To assess the possible functional effect of Stamp1 and Stamp2
knockdown on 3T3-L1 cells, we differentiated sh-St1, sh-St2, sh-
GFP and the wild type (WT) cells into adipocytes in the presence
or absence of pioglitazone (Pio), an agonist of Pparc and a known
promoter of adipogenesis [31]. The cells were stained for lipid
accumulation with Oil Red O to determine the extent of
differentiation. The WT and sh-GFP cells showed similar levels
of adipogenic conversion, distinctly increased compared to
undifferentiated WT cells (Figures 3A and 3B). Differentiation in
the presence of Pio further increased adipogenesis for WT and sh-
GFP cells with 30% and 35%, respectively, consistent with
previous findings [32]. sh-St1 and sh-St2 cells had significantly
lower levels of differentiation (70% and 40%, respectively) in
regular differentiation medium compared with the WT and sh-
GFP control cells (Figures 3A and 3B). However, in the presence
of Pio, this defect was rescued and the differentiation of sh-St1 and
sh-St2 cells was comparable to that of WT and sh-GFP cells.
These data show that Stamp1 or Stamp2 knockdown impairs
adipogenesis and that this may be due to disrupted Pparc
signaling.
We have previously shown that STAMP1 and STAMP2 both
increase human prostate cancer cell proliferation [33–35]. Since
both Stamp1 and Stamp2 are differentially regulated during 3T3-L1
adipogenesis (Figures 1A and 1B), we examined if silenced
expression of either would 3T3-L1 cell proliferation. To that
end, equal numbers of WT, sh-GFP, sh-St1 and sh-St2 cells were
cultured, induced with an adipogenic cocktail with or without Pio
and cell numbers determined after 8 days of differentiation
(Figure 3C). Without Pio, there was no difference in cell number of
the WT, sh-GFP and sh-St2 adipocytes. However, the sh-St1 cell
growth was retarded by 40–50% compared with sh-GFP cells,
suggesting that the mitotic clonal expansion phase of 3T3-L1
adipogenesis is blocked upon Stamp1 loss [7]. Differentiation in the
presence of Pio did not affect cell growth at day 8 of differentiation
for WT, sh-GFP and sh-St2 cells. In contrast, Pio partially rescued
the cell number defect in sh-St1 cells with an increase from 40–
50% to 65% compared to that of sh-GFP cells. This partial rescue
was already maximal with 1 mM Pio and did not increase further
up to 8 mM (Figure 3D). Taken together, these data show that
Stamp1 or Stamp2 knockdown inhibits adipogenesis, and in the case
of Stamp1, this may be, at least in part, through disruption of the
mitotic clonal expansion in 3T3L1 cells.
Stamp1 and Stamp2 Knockdown Affects Stamp
Expression in 3T3-L1 Adipocytes
As presented above, all Stamps are expressed and regulated
during 3T3-L1 adipogenesis (Figure 1). To assess whether Stamp1
or Stamp2 knockdown influences expression of other Stamps, we
determined Stamp expression in WT, sh-GFP, sh-St1 and sh-St2
cells at different time points during adipogenesis. As previously
observed, Stamp1 expression was decreased by 85% in sh-St1 cells,
compared to WT and sh-GFP cells at day 0 (Figure 4A). At day 8,
Stamp1 levels were 60% lower in WT and sh-GFP cells compared
with the same cells at day 0, consistent with Figure 1A, and
remained low in sh-St1 cells. Interestingly, in sh-St2 cells, Stamp1
expression increased by about 2-fold at day 8 of differentiation
compared to WT and sh-GFP cells, but this was lost upon Pio
treatment suggesting that Pparc may inhibit Stamp1 expression in
these cells.
Stamp2 expression was low at day 0 and increased dramatically
in WT and sh-GFP cells at day 8 of differentiation (Figure 4B).
Consistent with Figure 2B, Stamp2 expression was decreased by
90% in sh-St2 cells. Interestingly, at day 8, Stamp2 expression in
sh-St1 cells was reduced by 60% compared to WT and sh-GFP
cells. In the presence of Pio, Stamp2 expression in WT, sh-GFP and
sh-St2 cells increased by about 2.5-fold compared to levels at day 8
in the absence of Pio. In contrast, Stamp2 levels in the sh-St1 cells
rose by nearly 5-fold to reach comparable levels of WT and sh-
Stamps in Adipogenesis
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GFP cells in response to Pio. These data suggest that Pparc
activation in increases Stamp2 expression.
We also assessed Stamp3 levels and observed no change in
expression under similar conditions (Figure 4C), except for in sh-
St1 cells where Stamp3 expression was 2-fold higher at day 8 and
65% higher at day 8+ Pio compared with at day 0. These data
suggest that Stamp1 and Stamp3 may have overlapping roles in
3T3-L1 adipocytes.
Stamp1 or Stamp2 Knockdown Interferes with
Adipogenic Gene Expression
The data presented above showed that Stamp1 or Stamp2
knockdown suppresses 3T3-L1 differentiation (Figures 3A and 3B).
We thus investigated whether the expression of a common
adipogenic marker, aP2, and the two main transcription factors
regulating adipogenesis, Pparc and C/ebpa [36], were affected by
Stamp knockdown. We first determined mRNA expression of aP2,
Pparc and C/ebpa in WT, sh-GFP, sh-St1 and sh-St2 cells at
different time points during adipogenesis. aP2 expression was not
detected at day 0 of differentiation (Figure 4D), but was present at
day 8 for all cell lines. Consistent with the observed reduction in
differentiation of sh-St1 and sh-St2 cells presented above
(Figures 3A and 3B), aP2 expression was 50% lower in these cells
compared to WT and sh-GFP cells. At day 8+ Pio, aP2 expression
increased significantly in all cell types, and its levels in sh-St1 cells
were now similar to that found in the WT or sh-GFP cells, in
agreement with the rescue effect of Pio on the differentiation of sh-
St1 cells (Figures 3A and 3B). Surprisingly, although aP2
expression in sh-St2 cells was 2-fold upregulated at day 8+ Pio
compared to day 8, the aP2 mRNA levels were still 40% lower at
day 8+ Pio compared to sh-GFP cells. This suggests that aP2 levels
Figure 1. Regulation of Stamp family expression during 3T3-L1 adipogenesis. (A–C) qRT-PCR analysis of 3T3-L1 cells harvested at the
indicated time points (days) of differentiation. The figures show the mRNA expression of Stamp1 (A), Stamp2 (B, top), and Stamp3 (C) normalized to
the reference gene 36B4. The results are from three independent experiments, n = 9. *p,0.05 compared to d0; #p,0.05 between brackets. (B,
bottom) Western analysis showing Stamp2 and b-actin protein levels from day 0 to day 8 of differentiation in 3T3-L1 cells harvested in parallel to
those used for qRT-PCR analysis. The figure presented is representative of two independent experiments.
doi:10.1371/journal.pone.0068249.g001
Figure 2. Stamp1 or Stamp2 knockdown in 3T3-L1 cells. (A–B) qRT-PCR analysis of WT, sh-GFP, sh-St1 and sh-St2 cells. The figures show relative
mRNA expression of Stamp1 (A) and Stamp2 (B) normalized to the reference gene 36B4 from one experiment, n = 3. *p,0.05 compared to sh-GFP
cells. The data presented are representative of three independent experiments. (C) Western analysis showing Stamp2 and b-actin protein levels at day
8 of differentiation in WT, sh-GFP and sh-St2 cells. The data presented are representative of two independent experiments.
doi:10.1371/journal.pone.0068249.g002
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Figure 3. Stamp1 or Stamp2 knockdown reduces 3T3-L1 adipogenesis. (A–B) Oil Red O staining of WT, sh-GFP, sh-St1 and sh-St2 cells
differentiated with pioglitazone (Pio) or vehicle (Ctrl). (A) Representative images of the staining. (B) Quantification from three independent
experiments, n = 9. *p,0.05 compared to sh-GFP cells; #p,0.05 between Ctrl and Pio groups. (C) Relative cell number of the same cells as in (A). The
results are from three independent experiments, n = 9. *p,0.05 compared to sh-GFP cells; #p,0.05 between Ctrl and Pio groups. (D) Relative cell
number of sh-St1 cells differentiated with increasing concentrations of Pio. The results are from one experiment, n = 3. *p,0.05 compared to shGFP;
#p,0.05 between brackets.
doi:10.1371/journal.pone.0068249.g003
Stamps in Adipogenesis
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generally correlated with differentiation properties of the different
cells lines, except for in sh-St2 cells.
There was no significant difference in the Pparc expression at
day 0 of differentiation among the different cell lines (Figure 4E).
At day 8, Pparc expression in WT and sh-GFP cells increased by
Figure 4. Stamp1 or Stamp2 knockdown reduces Pparc and aP2, but not C/ebpa, mRNA expression in 3T3-L1 adipocytes. (A–F) qRT-PCR
analysis of WT, sh-GFP, sh-St1 and sh-St2 cells harvested at day 0 (d0) and day 8 of differentiation with (d8+Pio) or without (d8) Pio. The figures show
the relative mRNA expression of Stamp1 (A), Stamp2 (B), Stamp3 (C), aP2 (D), Pparc (E), and C/ebpa (F) normalized to the reference gene 36B4 from
three independent experiments, n = 9. *p,0.05 compared to sh-GFP cells; #p,0.05 between brackets.
doi:10.1371/journal.pone.0068249.g004
Stamps in Adipogenesis
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about 20-fold compared with that observed at day 0, consistent
with previous findings [37]. In agreement with the reduction in
adipogenesis seen in Figures 3A and 3B, the sh-St1 and sh-St2 cells
had 40% less Pparc expression compared to sh-GFP cells.
Furthermore, consistent with the rescue effect on 3T3-L1
differentiation with Pio presented above, there was an overall
upregulation in Pparc expression at day 8+ Pio, where Pparc
expression in sh-St1 and sh-St2 cells was comparable to that in sh-
GFP cells. These data show that Pparc levels correlated well with
the differentiation properties of the different cell lines.
Similar to Pparc, C/ebpa expression was low for all cell lines at
day 0 of differentiation and increased by about 20-fold by day 8
(Figure 4F). However, unlike Pparc expression, all cell lines
displayed comparable C/ebpa expression at day 8. At day 8+ Pio,
there was a trend towards increased C/ebpa expression for all cell
lines. These data suggest that Stamp1 or Stamp2 knockdown do not
significantly affect C/ebpa expression.
We next investigated Pparc and C/ebpa protein expression in
the sh-GFP, sh-St1 and sh-St2 cells. These were harvested and cell
extracts were made at different time points during adipogenesis
and subjected to Western analysis. As shown in Figures 5A and 5B,
Pparc expression was not detectable at day 0, consistent with
Figure 4E and previous reports [37]. By day 4 of differentiation,
expression of both isoforms 1 and 2 of Pparc were detected. In
agreement with the observed mRNA expression (Figure 4E),
Pparc protein was expressed at 70% and 50% lower levels (for
both isoforms) in the sh-St1 and sh-St2 cells, respectively,
compared with sh-GFP cells. This decrease in expression was also
present at day 8 of differentiation as both sh-St1 and sh-St2 cells
had a 60% reduction in Pparc expression compared to sh-GFP
cells. Consistent with the mRNA levels presented in Figure 4E,
differentiation with Pio resulted in similar Pparc levels in both the
control and knockdown cells (Figures 5A and 5B).
Similarly, C/ebpa expression was low at day 0 and increased
40-fold when the sh-GFP cells reached day 4 of differentiation,
consistent with the data in Figure 4F. However, at day 4, the C/
ebpa protein levels were 70% and 60% lower in the sh-St1 and sh-
St2 cells, respectively, compared with sh-GFP cells. While C/ebpa
expression continued to increase by 2.5-fold from day 4 to day 8 of
differentiation in sh-GFP adipocytes, the expression in sh-St1 and
sh-St2 cells remained 60% and 70% lower, respectively. Treat-
ment with Pio rescued the loss in C/ebpa expression similar to
what was seen for Pparc (Figures 5A and 5C), but in contrast to
the lack of changes observed at its mRNA level (Figure 3F). These
data show that suppression of adipogenesis upon Stamp1 or Stamp2
knockdown is correlated to downregulation of Pparc and C/ebpa
protein expression.
Stamp1 or Stamp2 Knockdown do not Affect C/ebpb
Expression and Nuclear Localization at the Early Stages of
3T3-L1 Adipogenesis
The transcription factor C/ebpb is required for both Pparc and
C/ebpa expression early in adipogenesis [38]. We therefore
examined whether there were alterations in C/ebpb expression in
early 3T3-L1 differentiation upon Stamp1 or Stamp2 knockdown.
To that end, sh-GFP, sh-St1 and sh-St2 cells were harvested at
days 0, 1 and 2 of differentiation and C/ebpb expression was
determined (Figure 6). Consistent with previous findings [39], C/
ebpb was expressed at low levels in sh-GFP cells at day 0,
increased by approximately 3-fold by day 1, and remained
unchanged at day 2. The sh-St1 and sh-St2 cells expressed C/
ebpb at comparable levels to the sh-GFP cells at all time points
suggesting that C/ebpb expression is not affected by Stamp1 or
Stamp2.
C/ebpb phosphorylation has been reported to induce its
translocation to the centromeres of chromosomes, which has been
linked to regulation of mitotic clonal expansion in 3T3-L1
adipogenesis [39]. We examined if this process was affected by
Stamp1 or Stamp2 knockdown. WT, sh-GFP,sh-St1 and sh-St2 cells
were differentiated and C/ebpb localization was assessed with
immunofluorescence confocal microscopy (Figure S1). In all cell
lines, we observed the characteristic punctate localization of C/
ebpb [39]. These data suggest that C/ebpb expression and
localization are not affected by Stamp1 and Stamp2 knockdown.
Stamp2 Knockdown Reduces Superoxide Production in
3T3-L1 Cells Independent of Adipogenesis
When ectopically expressed in HEK293T cells, all Stamps
demonstrate metalloreductase activity [18] which is predicted to
be driven by NADPH oxidation. A byproduct of NADPH
oxidation is generation of superoxide which has been implicated
in adipogenesis [40]. To assess whether Stamp1 or Stamp2
knockdown affect superoxide production in adipocytes, we used
the nitroblue tetrazolium (NBT) assay on WT, sh-GFP, sh-St1 and
sh-St2 adipocytes [41]. There was a 40% and 50% reduction in
the generation of superoxide in the sh-St1 and sh-St2 cells,
respectively, compared to WT and sh-GFP cells (Figure 7). When
the cells were differentiated with Pio, the superoxide production
was unchanged for the WT, sh-GFP or sh-St2 cells. Interestingly,
Pio significantly increased superoxide levels in sh-St1 cells which
reached comparable levels to those in WT and sh-GFP cells.
These data indicate that both Stamp1 and Stamp2 play a role in
superoxide production in 3T3-L1 adipocytes and that the loss of
superoxide levels upon Stamp1 knockdown can be rescued by
Pparc activation.
Discussion
In this study, we examined the expression and possible function
of Stamp family members during adipogenic differentiation.
Previous work has shown that Stamp2 mRNA and protein
expression is upregulated during adipogenesis [20,21]. Stamp3
protein expression was also found upregulated by 75% in 3T3-L1
adipocytes compared to confluent fibroblasts [30]. Here we show
that Stamp1 and Stamp3 mRNA expression are also differentially
regulated during adipogenic conversion. These data, along with
the effects of Stamp1 and Stamp2 knockdown on adipogenic
conversion that we present, suggest that the Stamp family has a
significant role in regulating adipogenesis.
Stamp1 knockdown significantly reduced 3T3-L1 differentia-
tion (Figures 3A and 3B) which was unexpected as Stamp1 was
clearly downregulated upon adipogenic conversion (Figure 1A).
Assessment of the number of adipocytes revealed that the sh-St1
cells displayed stunted proliferation upon induction of differenti-
ation compared to the WT and sh-GFP cells suggesting that
Stamp1 knockdown interfered with the mitotic clonal expansion
(Figures 3C and 3D). The mechanism(s) through which Stamp1
may regulate mitotic clonal expansion is currently not known.
In contrast to sh-St1 cells, sh-St2 cells proliferated at the same
rate as the WT and sh-GFP cells during differentiation (Figure 3C)
indicating that the mechanisms through which Stamp1 and
Stamp2 regulate adipogenesis is different. Furthermore, there may
be differences in the functioning and regulation of the mouse and
human STAMP2 proteins. Inhibition of STAMP2 in human
preadipocytes using an antibody, or STAMP2 knockdown prior to
differentiation, did not affect adipogenesis [24,42]. In contrast,
there were clear inhibitory effects of Stamp2 knockdown in 3T3-
L1 cells (Figure 3A and 3B). However, it is important to note that
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Figure 5. Stamp1 or Stamp2 knockdown reduces Pparc and C/ebpa protein expression in 3T3-L1 adipocytes. (A) Western analysis
showing Pparc, C/ebpa and b-actin protein levels at day 0 (d0), day 4 (d4) and day 8 (d8) of differentiation in WT, sh-GFP, sh-St1 and sh-St2 cells, plus
cells at day 8 differentiated with Pio (d8+ Pio). The data presented are representative of two independent experiments. (B–C) Quantification of
Westerns in (A) with relative Pparc (B) and C/ebpa (C) protein levels normalized to b-actin from two independent experiments, n = 6. *p,0.05.
doi:10.1371/journal.pone.0068249.g005
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in the studies concerning Stamp2 in human preadipocytes, the
thiazolidinedione (TZD) rosiglitazone (Rosi), a Pparc activator,
was used to induce adipogenesis, rather than the regular
differentiation cocktail [31]. This could be, at least in part, the
reason for these differential findings.
Here, we also show that both TZDs, Rosi and Pio, counteracted
the inhibitory effect of Stamp2 knockdown on 3T3-L1 cell
differentiation (Figures 3A, 3B and S2). These data support the
notion that Pparc activation can circumvent Stamp2 knockdown-
mediated deficiency in adipogenesis in both mouse and human
cells. In agreement with the inhibitory effects of Stamp1 and Stamp2
knockdown on 3T3-L1 adipogenesis, Pparc expression was
inhibited in both the sh-St1 and sh-St2 cells (Figures 4E, 5A and
5B). Interestingly, C/ebpa mRNA expression was similar in sh-St1
and sh-St2 cells compared to WT and sh-GFP cells, but C/ebpa
protein levels were downregulated (Figures 4F, 5A and 5C); this
suggests that there may be posttranscriptional control mechanisms
that regulate C/ebpa expression. Consistent with the effect of Pio
on 3T3-L1 differentiation addressed above, the overall Pparc and
C/ebpa expression increased and the protein levels were restored
in sh-St1 and sh-St2 cells at day 8+Pio.
Functional C/ebpb expression and activity was previously
shown to be essential for inducing Pparc expression and for the
mitotic clonal expansion during adipogenesis [39]. However, there
was no difference in C/ebpb expression and localization between
sh-GFP, sh-St1 and sh-St2 cells (Figures 6 and S1). Consistent with
the stunted growth of the sh-St1 cells, we have previously shown
that STAMP1 knockdown in human prostate cancer cells
decreases proliferation by deregulating cell cycle related protein
expression and activation of the mitogen-activated protein kinase
(MAPK) pathway [35]. Whether Stamp1 could be involved in
regulation of similar events during 3T3-L1 adipogenesis would
need to be addressed in future studies.
Increased superoxide production was previously reported
during 3T3-L1 adipocyte maturation [40]. Consistently, sh-St1
and sh-St2 cells showed lower superoxide production than WT
and sh-GFP cells (Figure 7), and the generation of superoxide was
restored in sh-St1 cells when differentiated with Pio. However, in
sh-St2 cells superoxide levels remained low even with Pio. This
again supports the notion that Stamp1 and Stamp2 affect
adipogenesis through different mechanisms. These data are also
Figure 6. Stamp1 or Stamp2 knockdown does not affect C/ebpb
protein expression in early 3T3-L1 adipogenesis. (A) Western
analysis showing C/ebpb protein levels at day 0 (d0), day 1 (d1) and day
2 (d2) of differentiation with the same cells as in (5A). (B) Quantification
of Western analysis results in (A) with relative C/ebpb protein levels
normalized to b-actin from two independent experiments, n = 6.
#p,0.05 between brackets.
doi:10.1371/journal.pone.0068249.g006
Figure 7. Stamp2 knockdown reduces superoxide production in 3T3-L1 cells independent of adipocyte differentiation. (A–B) NBT
assay with WT, sh-GFP, sh-St1 and sh-St2 cells differentiated with (Pio) or vehicle (Ctrl). (A) Representative images of the staining. (B) Quantification
from three independent experiments, n = 9. *p,0.05 compared to sh-GFP cells; #p,0.05 between Ctrl and Pio groups.
doi:10.1371/journal.pone.0068249.g007
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consistent with the function of the metalloreductase domain of
Stamp2 that can reduce iron with NADPH as an electron donor
generating superoxide in the process [18]. Recently, an increase in
mammalian target of rapamycin complex 1 (mTORC-1) depen-
dent mitochondrial complex III superoxide production has been
found to be required for Pparc expression during adipocyte
differentiation [11]. It was also found that Forkhead box O 1
(FOXO1) contributes to regulating endogenous antioxidants along
with the increased ROS production during adipogenesis as
FOXO1 knockdown led to downregulation of antioxidants and
decreased 3T3-L1 differentiation [43]. Interestingly, in Stamp2
knockout mice several endogenous antioxidants are also down-
regulated [21]. Together with our findings, these point to a role of
Stamp2 as a direct activator of 3T3-L1 adipogenesis through
production of pro-adipogenic ROS signals. Another possibility is
that Stamp2 may have a more indirect role in this process by
contributing to antioxidant production that protects adipocytes
from increasing ROS levels during adipogenesis. If Stamp2 levels
are decreased, this will result in lower antioxidant production
during differentiation, which could force the cells to adapt to lower
ROS levels that can in turn retard the adipogenic conversion. In
support of the latter, increased ROS and decreased insulin
response was seen when STAMP2 was inhibited with an antibody
in mature human adipocytes [44].
In summary, our data suggest that the Stamp family may have
important roles in 3T3-L1 adipogenesis, which may involve
distinct pathways for the different Stamps. These data pave the
way to further explore the functions of the Stamp family in
adipogenesis.
Supporting Information
Figure S1 Stamp1 or Stamp2 knockdown does not affect C/ebpb
nuclear distribution in 3T3-L1 cells after induction of differenti-
ation. (A–B) Immunofluorescence confocal microscopy analysis of
expressed C/ebpb (green) in the nuclei (blue) of WT, sh-GFP, sh-
St1 and sh-St2 cells 16 h after induction of differentiation. (A)
Representative images of the staining from two independent
experiments. (B) Quantification from one experiment, n = 100.
(TIF)
Figure S2 Rosiglitazone reverses Stamp1 or Stamp2 knockdown-
induced decrease in adipogenesis. Oil Red O staining of WT, sh-
GFP, sh-St1 and sh-St2 cells differentiated with rosiglitazone (Rosi)
or vehicle (Ctrl). Figure shows quantification from one experiment,
n = 3. *p,0.05 compared to sh-GFP cells; #p,0.05 between Ctrl
and Rosi groups.
(TIF)
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